View More Recent Stories

Feb 19, 2025 08:53AM enVVeno Medical (NVNO): One-Year Data from the VenoValve U.S. Pivotal Trial Highlighting Impact on Patients' Quality of Life to be Presented Today
Feb 19, 2025 08:45AM One-Year Data from the VenoValve(R) U.S. Pivotal Trial Highlighting Impact on Patients' Quality of Life (QOL) to be Presented Today at the 37th Annual Meeting of the American Venous Forum
Feb 7, 2025 09:01AM enVVeno Medical (NVNO): Interim Two-Year Follow-Up Data from the VenoValve(R) U.S. Pivotal Trial to be Presented Today at the VESS 2025 Annual Winter Meeting
Feb 7, 2025 09:00AM Interim Two-Year Follow-Up Data from the VenoValve(R) U.S. Pivotal Trial to be Presented Today at the VESS 2025 Annual Winter Meeting
Dec 16, 2024 08:50AM enVVeno Medical Successfully Completes Final Wave of Implants in Pre-Clinical GLP Study for enVVe
Nov 27, 2024 08:30AM enVVeno Medical Highlights Successful 2024 VEITH Symposium with Launch of Recap Website
Nov 20, 2024 08:30AM enVVeno Medical to Present Definitive One Year Data from the VenoValve U.S. Pivotal Trial Today at the 51st Annual VEITH Symposium
Nov 19, 2024 08:16AM enVVeno Medical (NVNO) Submits the VenoValve PMA Application Seeking FDA Approval
Nov 19, 2024 08:15AM enVVeno Medical Submits the VenoValve PMA Application Seeking FDA Approval
Oct 31, 2024 08:35AM enVVeno Medical Reports Third Quarter 2024 Financial Results and Confirms Guidance for Release of Definitive VenoValve Data in November and Completion of FDA Premarket Approval Application for VenoVal
Oct 28, 2024 08:30AM enVVeno Medical Successfully Initiates 6-Month Pre-Clinical GLP Study Evaluating enVVe(R)
Sep 27, 2024 06:04AM enVVeno Medical (NVNO) Prices 4.3M Share and Warrant Offering at $3.50/sh
Sep 26, 2024 09:18PM enVVeno Medical Corporation Announces Pricing of $15.0 Million Public Offering
Sep 26, 2024 04:07PM enVVeno Medical (NVNO) Announces Proposed Share Offering
Sep 26, 2024 04:05PM enVVeno Medical Corporation Announces Proposed Public Offering
Sep 3, 2024 09:05AM enVVeno Medical (NVNO) Appoints Sandy Prietto as VP of Marketing
Sep 3, 2024 09:00AM enVVeno Medical Adds Sandy Prietto to its Executive Team as Vice President of Marketing
Aug 14, 2024 09:04AM enVVeno Medical (NVNO) Provides Update on FDA Premarket Approval Application Status for VenoValve
Aug 14, 2024 09:00AM enVVeno Medical Provides Update on FDA Premarket Approval Application Status for VenoValve(R)
Aug 1, 2024 08:05AM enVVeno Medical Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Jun 25, 2024 09:00AM enVVeno Medical to Participate in the Virtual Investor Closing Bell Series
Jun 25, 2024 09:00AM enVVeno Medical to Participate in the Virtual Investor Closing Bell Series
Jun 25, 2024 09:00AM enVVeno Medical to Participate in the Virtual Investor Closing Bell Series
Jun 21, 2024 08:37AM enVVeno Medical (NVNO) Reports Positive Interim Venous Ulcer Healing Data
Jun 21, 2024 08:35AM Positive Interim Venous Ulcer Healing Data Showing Significant Improvement from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented Today at the Society for Vascular Surgery 2024 Vascular A
Jun 17, 2024 12:00PM New Interim Venous Ulcer Healing Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the Society for Vascular Surgery 2024 Vascular Annual Meeting on June 21, 2024
View More Recent Stories